Social media, a measurable part of marketing plans

Share this article:

Social media continues to be something of a blind spot for the pharma and medical device industries, with only a tiny fraction of all marketing dollars spent on online marketing. Today, the large majority of adult consumers are online, and over 50% find health information online. The average physician spends upward of eight hours online for work every week, and uses a handheld device to look up information while with patients. Yet there is still this big wonder: How should the industry approach marketing of pharma and medical products using social media? How do we stay within the FDA rules? How do we deal with adverse events and reporting? How do we keep people from saying bad things about us? How do we promote our products without annoying or alienating our audiences?

All great questions, but it's time to stop the negativity, and focus on good solid strategy. It's time to build integrated acquisition, conversion and compliance marketing programs that include more of the measurable online media in conjunction with traditional media. Today, we know the majority of patients are online looking for health information and they're discussing it via social media. They look up information before talking with doctors, and before getting surgery. Today, they are making educated health decisions with their doctors.

Rather than avoiding social media, let's join the party. For starters, let's get the brainstorms going and step outside the (FDA) box. Start conversations in new ways with patients and doctors. Let them tell us what they want. I'm not saying we should disregard the FDA, but it's time to think about new ideas first. Then figure out how the rules come into play.

UCB and are leading the charge with a new online epilepsy patient community. Their goal is to better understand people living with epilepsy, in a measurable way.

We can't wait for the FDA to deliver a list of Internet rules, because the Internet will have changed so many times between now and then, the rules will already be out of date. Instead, we need to take charge, look outside the box and include social media as a sound, measurable part of our comprehensive, integrated acquisition, conversion and compliance programs.

Ed Feather is senior brand director, PARTNERS+simons
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?